Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Clinical AI company Abridge is moving beyond the bedside and into the billing department. Its new pre-bill review tool checks inpatient claims before submission, flagging mismatches between coded diagnoses and what the clinical documentation actually supports. The goal: fewer denials, faster reimbursements, and cleaner claims — all without taking control away from CDI and coding teams.
Clinical AI company Abridge — best known for its ambient listening and AI-generated clinical notes — is now taking aim at one of healthcare's most persistent headaches: the gap between what care was delivered and what actually gets reimbursed. The company launched a pre-bill review tool that scans inpatient claims before submission, comparing coded diagnoses and diagnosis-related groups (DRGs) against the underlying clinical documentation to catch discrepancies early. CDI and coding teams retain full control over what to hold, correct, or release.
The move is a natural extension of Abridge's broader "clinical intelligence" platform strategy — carrying the same clinical record from the point of care all the way through to the submitted claim. The tool also helps teams assess whether conditions were present on admission (POA), a determination that affects hospital-acquired condition reporting and publicly reported quality scores.
By the Numbers:
Why it matters: Inaccurate claims don't just mean denials — they trigger costly rework, delay cash flow, and drain clinical and administrative resources. By connecting clinical documentation directly to the billing workflow, Abridge is betting that getting the claim right the first time can meaningfully improve health system finances.
